Medical Condition

inflammation

Total Trials

18

Recruiting Now

18

Trial Phases

Phase 3, Phase 4

ClinicalMetric tracks all active clinical trials for inflammation sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
Phase 1–4 studies from early safety trials to post-marketing surveillance
NIH, pharmaceutical sponsor, and academic medical center studies worldwide
AI-powered plain-language summary available for every trial listing

Frequently Asked Questions — inflammation Clinical Trials

How many clinical trials are currently recruiting for inflammation?

ClinicalMetric currently tracks 18 actively recruiting clinical trials for inflammation, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 18. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for inflammation?

inflammation research spans Phase 3 (2 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a inflammation clinical trial?

Eligibility criteria for inflammation trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 3

Phase 4

Top Sponsors

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 1 trial

Beth Israel Deaconess Medical Center 1 trial

The University of Texas Health Science Center at San Antonio 1 trial

Peking Union Medical College Hospital 1 trial

Palacky University 1 trial

inflammation

Frequently Asked Questions — inflammation Clinical Trials

Recruiting Clinical Trials

Study on Ketorolac for Improving Outcomes and Prognosis in Patients With Stanford Type A Aortic Dissection

Biomarkers in Infection

Wellness App for Sleep Disturbance in Hematological Cancer Patients

Clinical Features, Current Treatment and Clinical Outcomes in Patients With INR-CAD: a Cohort Study

Evaluation of Molecular Hydrogen Supplementation to Enhance the Efficacy of Weight Loss Retreat in Overweight and Obese Adolescents

Comorbid Obesity and Depression With an Anti-inflammatory Medication

Pilot Study on HA380 Column Use in Critically Ill Patients Receiving Extracorporeal Support.

Diagnosis and Management of Inflammatory and Infectious Diseases

Effects of Increased Greek Yogurt Consumption in Youth and Young Adult Athletes

Diagnosing Asthma With Clinically Accessible, Non-invasive, and Efficient Tests: a Child-inclusive Translational Investigation

Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents

Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk

UCLA REST Study (REsearch on Sleep Techniques)

The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies

Validation and Simplification of the Retinol Isotope Dilution Technique in Burkinabe Schoolchildren

Iron Absorption and Losses in Young South African Women Living Without and With Overweight and Obesity

Prognostic Value of SII and SIRI in Obesity-Related Metabolic Complications

Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced Wheezing